P. Koldovský

954 total citations
70 papers, 690 citations indexed

About

P. Koldovský is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, P. Koldovský has authored 70 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Molecular Biology and 19 papers in Immunology. Recurrent topics in P. Koldovský's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Cells and Metastasis (9 papers) and Immunotherapy and Immune Responses (9 papers). P. Koldovský is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Cells and Metastasis (9 papers) and Immunotherapy and Immune Responses (9 papers). P. Koldovský collaborates with scholars based in Germany, United States and Italy. P. Koldovský's co-authors include J Bubeník, Hilary Koprowski, Werner Henle, Peter K. Vogt, P. H. Hofschneider, L Syrůcek, R. Rott, O. Maaløe, Barbara Hildebrandt and Fritz Melchers and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

P. Koldovský

69 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Koldovský Germany 14 275 244 139 137 85 70 690
H G Bedigian United States 18 540 2.0× 435 1.8× 153 1.1× 367 2.7× 78 0.9× 44 1.2k
T S Papas United States 11 481 1.7× 209 0.9× 103 0.7× 113 0.8× 53 0.6× 15 803
Claire Y. Dunn United States 9 398 1.4× 107 0.4× 194 1.4× 245 1.8× 54 0.6× 11 679
A. Declève United States 20 294 1.1× 391 1.6× 223 1.6× 432 3.2× 130 1.5× 41 1.0k
Samuel Salzberg Israel 21 420 1.5× 274 1.1× 134 1.0× 175 1.3× 114 1.3× 62 1.0k
John Jainchill United States 6 545 2.0× 153 0.6× 189 1.4× 426 3.1× 69 0.8× 7 966
J. T. Grace United States 13 175 0.6× 197 0.8× 221 1.6× 252 1.8× 38 0.4× 36 778
S A Okenquist United States 8 421 1.5× 168 0.7× 84 0.6× 213 1.6× 21 0.2× 9 649
Carole Kurahara United States 10 180 0.7× 390 1.6× 127 0.9× 129 0.9× 91 1.1× 12 682
Linda M. Karavodin United States 12 170 0.6× 240 1.0× 89 0.6× 88 0.6× 129 1.5× 18 556

Countries citing papers authored by P. Koldovský

Since Specialization
Citations

This map shows the geographic impact of P. Koldovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Koldovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Koldovský more than expected).

Fields of papers citing papers by P. Koldovský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Koldovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Koldovský. The network helps show where P. Koldovský may publish in the future.

Co-authorship network of co-authors of P. Koldovský

This figure shows the co-authorship network connecting the top 25 collaborators of P. Koldovský. A scholar is included among the top collaborators of P. Koldovský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Koldovský. P. Koldovský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koldovský, P., I. Haas, & U. Ganzer. (1996). Promoting Effects of Fibroblasts on Growth and Progression of Head and Neck Carcinoma Cells. ORL. 58(5). 248–252. 2 indexed citations
2.
Gerharz, C D, Barbara Hildebrandt, R. Moll, et al.. (1996). Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines. British Journal of Cancer. 74(10). 1605–1614. 11 indexed citations
3.
Haas, I. & P. Koldovský. (1996). Expression von zellulären Antigenen eines Hypopharynxkarzinoms unter verschiedenen Kulturbedingungen. Laryngo-Rhino-Otologie. 75(9). 543–547. 1 indexed citations
4.
Koldovský, P., I. Haas, H. Bier, & U. Ganzer. (1995). Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases. European Archives of Oto-Rhino-Laryngology. 252(6). 359–65. 4 indexed citations
5.
Gerharz, Claus‐Dieter, R. Moll, S Störkel, et al.. (1995). Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.. PubMed. 146(4). 953–62. 23 indexed citations
6.
Kita, Jun, et al.. (1993). Inhibition of Head and Neck Tumor Cell Colony Growth by Lymphokine Activated Killer Cells. Acta Oto-Laryngologica. 113(sup500). 138–141. 2 indexed citations
7.
Heß, Markus, et al.. (1993). Morphologic Analysis of Three-Dimensional Tumors Developed in Fibrin Matrix and Agar Culture System. Pathobiology. 61(1). 31–35. 4 indexed citations
8.
Koldovský, P., H. Bier, & U. Ganzer. (1992). Induction of transformation of human respiratory epithelium in vitro. European Archives of Oto-Rhino-Laryngology. 249(6). 344–8. 2 indexed citations
9.
Koldovský, P., et al.. (1991). Etablierung Dreidimensionaler Tumoren In Vitro und Wirkung von Lymphokinaktivierten Killer (Lak)-Zellen Auf Die Dreidimensionalen Tumoren. Auris Nasus Larynx. 18(3). 235–269. 1 indexed citations
10.
Koldovský, P., et al.. (1989). Effect of Lymphokine-activated Killer Cells on Head and Neck Tumours in Nude Mouse Model. Acta Oto-Laryngologica. 108(5-6). 317–324. 4 indexed citations
11.
Koldovský, P., et al.. (1989). Use of the subrenal capsule assay to measure antibody-dependent, cell-mediated cytotoxicity against head and neck tumors. European Archives of Oto-Rhino-Laryngology. 246(3). 165–168. 1 indexed citations
12.
Lindenberger, Jared, et al.. (1986). Xenografting of Nasopharyngeal Carcinoma into Athymic Mice. ORL. 48(1). 1–7. 4 indexed citations
13.
Koldovský, P., et al.. (1986). Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas. European Archives of Oto-Rhino-Laryngology. 243(5). 309–312. 3 indexed citations
14.
Arber, Werner, Werner Henle, P. H. Hofschneider, et al.. (1978). Current Topics in Microbiology and Immunology. Current topics in microbiology and immunology. 9 indexed citations
15.
Barańska, W, P. Koldovský, & Hilary Koprowski. (1970). Antigenic Study of Unfertilized Mouse Eggs: Cross Reactivity with SV40-Induced Antigens. Proceedings of the National Academy of Sciences. 67(1). 193–199. 38 indexed citations
16.
Koldovský, P.. (1966). DANGERS AND LIMITATIONS OF THE IMMUNOLOGICAL TREATMENT OF CANCER. The Lancet. 287(7438). 654–655. 8 indexed citations
17.
Bubeník, J, J Iványi, & P. Koldovský. (1965). Participation of 7S and 19S antibodies in enhancement and resistance to methylcholanthrene-induced tumours.. PubMed. 11(6). 426–33. 16 indexed citations
18.
Hasek, M, J Svoboda, & P. Koldovský. (1963). Immunological tolerance and the cancer problem.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations
19.
Koldovský, P.. (1961). Isoimmunity against an induced primary tumour.. PubMed. 7. 170–2. 2 indexed citations
20.
Koldovský, P.. (1961). Passive transfer of anti-tumour isoimmunity.. PubMed. 7. 157–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026